These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 38416279)

  • 21. How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
    Han R; Gomez JA; de Veras B; Pinto T; Guzman-Holst A; Nieto J; van Oorschot DAM
    Hum Vaccin Immunother; 2023 Dec; 19(1):2164144. PubMed ID: 36821856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review.
    Badur S; Senol E; Azap A; Yesiloglu C; Ozakay A; Ozturk S; Guzman-Holst A
    Infect Dis Ther; 2023 Aug; 12(8):1937-1954. PubMed ID: 37530949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany.
    Curran D; Van Oorschot D; Matthews S; Hain J; Salem AE; Schwarz M
    Hum Vaccin Immunother; 2021 Dec; 17(12):5296-5303. PubMed ID: 34905463
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Patil A; Goldust M; Wollina U
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genital Herpes Zoster as Possible Indicator of HIV Infection.
    Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Harpaz R; Ortega-Sanchez IR; Seward JF;
    MMWR Recomm Rep; 2008 Jun; 57(RR-5):1-30; quiz CE2-4. PubMed ID: 18528318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes Zoster Ophthalmicus: A Devastating Disease Coming Back with Vengeance or Finding Its Nemesis?
    Tsatsos M; Athanasiadis I; Myrou A; M Saleh G; Ziakas N
    J Ophthalmic Vis Res; 2022; 17(1):123-129. PubMed ID: 35194502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Johnson RW; Whitton TL
    Expert Opin Pharmacother; 2004 Mar; 5(3):551-9. PubMed ID: 15013924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Herpes Zoster in Adults in Mexico: A Retrospective Database Analysis.
    Guzman-Holst A; Cervantes-Apolinar MY; Favila JCT; Huerta-Garcia G
    Infect Dis Ther; 2023 Jan; 12(1):131-141. PubMed ID: 36348227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?
    Harbecke R; Jensen NJ; Depledge DP; Johnson GR; Ashbaugh ME; Schmid DS; Breuer J; Levin MJ; Oxman MN
    Vaccine; 2020 Jan; 38(2):150-157. PubMed ID: 31679866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.
    Johnson RW; Bouhassira D; Kassianos G; Leplège A; Schmader KE; Weinke T
    BMC Med; 2010 Jun; 8():37. PubMed ID: 20565946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Stankus SJ; Dlugopolski M; Packer D
    Am Fam Physician; 2000 Apr; 61(8):2437-44, 2447-8. PubMed ID: 10794584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
    Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
    BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: Data from an integrated health care network.
    Sun X; Wei Z; Lin H; Jit M; Li Z; Fu C
    J Infect; 2021 Feb; 82(2):253-260. PubMed ID: 33359014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes zoster guideline of the German Dermatology Society (DDG).
    Gross G; Schöfer H; Wassilew S; Friese K; Timm A; Guthoff R; Pau HW; Malin JP; Wutzler P; Doerr HW
    J Clin Virol; 2003 Apr; 26(3):277-89; discussion 291-3. PubMed ID: 12637076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpes zoster in outpatient departments of healthcare centers in India: a review of literature.
    Patki A; Vora A; Parikh R; Kolhapure S; Agrawal A; Dash R
    Hum Vaccin Immunother; 2021 Nov; 17(11):4155-4162. PubMed ID: 34520327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shingrix for Herpes Zoster: A Review.
    Shah RA; Limmer AL; Nwannunu CE; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 Jul; 24(4):5-7. PubMed ID: 31339679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
    Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N
    Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chickenpox exposure and herpes zoster disease incidence in older adults in the U.S.
    Chaves SS; Santibanez TA; Gargiullo P; Guris D
    Public Health Rep; 2007; 122(2):155-9. PubMed ID: 17357357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer.
    Curran D; Patterson BJ; Carrico J; Salem A; La EM; Lorenc S; Hicks KA; Poston S; Carpenter CF
    Hum Vaccin Immunother; 2023 Dec; 19(1):2167907. PubMed ID: 36880669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.